HIV lipodystrophy and its metabolic consequences: implications for clinical practice.

HIV lipodystrophy and its metabolic consequences: implications for clinical practice.

Item
http://www.wikidata.org/entity/Q37061566
A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalizationA cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 studyGetting to 90-90-90 in paediatric HIV: What is needed?Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study.The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected childrenDiagnosis and management of common chronic metabolic complications in HIV-infected patients.Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature.Therapy for HIV: past, present, and future.Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy.Diagnosis and treatment of severe hypertriglyceridemia.Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications.Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.
P2860

HIV lipodystrophy and its metabolic consequences: implications for clinical practice.

Item
http://www.wikidata.org/entity/Q37061566
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
@en
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
@nl
type
label
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
@en
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
@nl
prefLabel
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
@en
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
@en
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921